Hypostatic eczema
Conditions
Interventions
Cetomacrogol creme versus MMRC
Sponsors
BAP medical-medical care for the skin
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Patient older than 18 years Patient with venous eczema and venous leg ulcus Severety eczema mild-POEM score 8-16 2 treatments a day possible signed informed consent
Exclusion criteria
Exclusion criteria: allergic for MMRC or cetomacrogol other type of eczema treated in the last 4 weeks with one of the study cream or a corticosteroid cream EAI
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome measure: percentage of patients with eczema healed in a 6-week period. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary Objective (s): 1. Percentage of patients with a reduction in the severity of the eczema. 2. Time to cure 3. Percentage of patients who have reduced the severity of itching symptoms, measured with the VAS scale. 4. The number of patients who decided to prescribe local corticosteroids in the course of the study (= end of study participation). | — |
Countries
Netherlands
Outcome results
None listed